Over the past 50 years, the quest for biomarkers has substantially risen, with numerous effects on human health. In order to create prospective new therapeutic core targets, biomarkers are crucial for determining the disease's underlying mechanisms. Biomarkers reveal the pathophysiological stages of several diseases for which there are various clinical guidelines that clearly indicate diagnosis, prevention, and evidence-based treatment (such as heart failure). Biomarkers are evolving into potent tools for stratifying patients based on their likelihood of disease development, determining disease severity, and directing therapy. Additionally, in clinical trials, biomarkers can be employed as indicators of the efficacy and safety of novel pharmaceutical therapies or therapeutic interventions.
Read More- https://coherentmarketinsightsus.blogspot.com/2022/12/biomarkers-are-characteristics-that-can.html
